Emerging and Novel Therapeutic Approaches in the Treatment of Male Erectile Dysfunction
Overview
Authors
Affiliations
Over the past few decades, a dramatic increase in our understanding of the pathophysiology of penile erection has occurred. The advent of phosphodiesterase type 5 inhibitors has revolutionized the treatment of erectile dysfunction (ED), while the introduction of modern penile prosthesis has almost completely replaced the need for vascular surgery. Despite the efficacy of current therapeutic options for ED, they are not without limitations and remain insufficient to address the growing patient population and various underlying medical conditions. Newer and novel ED therapies aspire to treat underlying microvascular abnormalities, prevent cavernosal fibrosis, promote endothelial revascularization, modulate neurohormonal pathways, and regenerate new penile tissue.
A Review of Current and Emerging Therapeutic Options for Erectile Dysfunction.
Chung E Med Sci (Basel). 2019; 7(9).
PMID: 31470689 PMC: 6780857. DOI: 10.3390/medsci7090091.
Canadian consensus algorithm for erectile rehabilitation following prostate cancer treatment.
Elterman D, Petrella A, Walker L, Van Asseldonk B, Jamnicky L, Brock G Can Urol Assoc J. 2018; 13(8):239-245.
PMID: 30526799 PMC: 6737730. DOI: 10.5489/cuaj.5653.
Jepps T, Olesen S, Greenwood I, Dalsgaard T Br J Pharmacol. 2016; 173(9):1478-90.
PMID: 26802314 PMC: 4831315. DOI: 10.1111/bph.13444.
Psychosocial perspectives on sexual recovery after prostate cancer treatment.
Walker L, Wassersug R, Robinson J Nat Rev Urol. 2015; 12(3):167-76.
PMID: 25753250 DOI: 10.1038/nrurol.2015.29.
Current status of penile rehabilitation after radical prostatectomy.
Kim J, Lee S Korean J Urol. 2015; 56(2):99-108.
PMID: 25685296 PMC: 4325125. DOI: 10.4111/kju.2015.56.2.99.